Cargando…

Novel strategies for the prevention of dementia from Alzheimer's disease

As the world's population continues to age, Alzheimer's disease presents a homing public health crisis that left unchecked, threatens to overwhelm health care systems throughout the developed world, in order to significantly tackle the most catastrophic and devastating symptom of Alzheimer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shineman, Diana W., Fillit, Howard M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Les Laboratoires Servier 2009
Materias:	Translational Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181917/ https://www.ncbi.nlm.nih.gov/pubmed/19585948

Ejemplares similares

Beyond amyloid: a diverse portfolio of novel drug discovery programs for Alzheimer's disease and related dementias
por: Lane, Rachel F, et al.
Publicado: (2011)

Diverse therapeutic targets and biomarkers for Alzheimer's disease and related dementias: report on the Alzheimer's Drug Discovery Foundation 2012 International Conference on Alzheimer's Drug Discovery
por: Lane, Rachel F, et al.
Publicado: (2013)

A diverse portfolio of novel drug discovery efforts for Alzheimer's disease: Meeting report from the 11th International Conference on Alzheimer's Drug Discovery, 27-28 September 2010, Jersey City, NJ, USA
por: Lee, Linda H, et al.
Publicado: (2010)

Progress in novel cognitive enhancers for cognitive aging and Alzheimer’s disease
por: Shineman, Diana W, et al.
Publicado: (2013)

Meeting the unique challenges of drug discovery for neurodegenerative diseases
por: Shineman, Diana W, et al.
Publicado: (2009)

Meeting report on the Alzheimer’s Drug Discovery Foundation 14th International Conference on Alzheimer’s Drug Discovery
por: Friedman, Lauren G, et al.
Publicado: (2014)

Translating the biology of aging into novel therapeutics for Alzheimer disease
por: Hara, Yuko, et al.
Publicado: (2019)

Self‐reported diabetes is associated with allocentric spatial processing in the European Prevention of Alzheimer's Dementia Longitudinal Cohort Study
por: Gregory, Sarah, et al.
Publicado: (2022)

Rasagiline effects on glucose metabolism, cognition, and tau in Alzheimer's dementia
por: Matthews, Dawn C., et al.
Publicado: (2021)

Mechanism-based treatments for Alzheimer's disease
por: Davies, Peter, et al.
Publicado: (2009)

Early detection of Alzheimer's disease: new diagnostic criteria
por: Dubois, Bruno, et al.
Publicado: (2009)

The epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity?
por: Millan, Mark J.
Publicado: (2014)

Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studies
por: Shineman, Diana W, et al.
Publicado: (2011)

Biological markers for early detection and pharmacological treatment of Alzheimer's disease
por: Hampel, Harald, et al.
Publicado: (2009)

Peripheral transcriptomic biomarkers for early detection of sporadic Alzheimer disease?
por: Hadar, Adva, et al.
Publicado: (2018)

Comparison of novel ventricular pacing strategies using an electro-mechanical simulation platform
por: Meiburg, Roel, et al.
Publicado: (2023)

A proteomic atlas of the neointima identifies novel druggable targets for preventive therapy
por: Wierer, Michael, et al.
Publicado: (2021)

Development of a Dementia-Focused End-of-Life Planning Tool: The LEAD Guide (Life-Planning in Early Alzheimer’s and Dementia)
por: Dassel, Kara, et al.
Publicado: (2019)

A randomized phase I study of methanesulfonyl fluoride, an irreversible cholinesterase inhibitor, for the treatment of Alzheimer's disease
por: Moss, Donald E, et al.
Publicado: (2013)

Methodological challenges in assessing the impact of comorbidities on costs in Alzheimer’s disease clinical trials
por: Kahle-Wrobleski, Kristin, et al.
Publicado: (2014)

The European Prevention of Alzheimer's Dementia Programme: An Innovative Medicines Initiative-funded partnership to facilitate secondary prevention of Alzheimer's disease dementia
por: Saunders, Stina, et al.
Publicado: (2022)

Novel therapeutic strategy targeting the Hedgehog signalling and mTOR pathways in biliary tract cancer
por: Zuo, M, et al.
Publicado: (2015)

An MRI-based strategy for differentiation of frontotemporal dementia and Alzheimer’s disease
por: Yu, Qun, et al.
Publicado: (2021)

Innate immunity in Alzheimer’s disease: the relevance of animal models?
por: Franco Bocanegra, Diana K., et al.
Publicado: (2017)

Nutrition and prevention of Alzheimer’s dementia
por: Swaminathan, Arun, et al.
Publicado: (2014)

A call for comparative effectiveness research to learn whether routine clinical care decisions can protect from dementia and cognitive decline
por: Dacks, Penny A., et al.
Publicado: (2016)

Epigenetic Epidemiology of Common Complex Disease: Prospects for Prediction, Prevention, and Treatment
por: Relton, Caroline L., et al.
Publicado: (2010)

Commentary: Global Alzheimer's disease and Alzheimer's disease related dementia research funding organizations support and engage the research community throughout the COVID‐19 pandemic
por: Meyers, Emily A., et al.
Publicado: (2021)

Predicted Lifetime Health Outcomes for Aducanumab in Patients with Early Alzheimer’s Disease
por: Herring, William L., et al.
Publicado: (2021)

Prevention strategies for Alzheimer’s disease
por: Gauthier, Serge, et al.
Publicado: (2012)

Depression—an underrecognized target for prevention of dementia in Alzheimer’s disease
por: Dafsari, Forugh S., et al.
Publicado: (2020)

Will Nicotine Genetics and a Nicotine Vaccine Prevent Cigarette Smoking and Smoking-Related Diseases?
por: Hall, Wayne D
Publicado: (2005)

Secondary prevention of Alzheimer’s dementia: neuroimaging contributions
por: ten Kate, Mara, et al.
Publicado: (2018)

Treatment patterns and burden of behavioral disturbances in patients with dementia in the United States: a claims database analysis
por: Aigbogun, Myrlene Sanon, et al.
Publicado: (2019)

A Case of Suppurative Pleuritis with Gangrene of a Portion of Lung Tissue and Its Escape from the Operation Wound
por: Wagner, W., et al.
Publicado: (1881)

Fitting the epidemiology and neuropathology of the early stages of Alzheimer’s disease to prevent dementia
por: Mar, Javier, et al.
Publicado: (2015)

Could lysine supplementation prevent Alzheimer’s dementia? A novel hypothesis
por: Rubey, Robert N
Publicado: (2010)

Pharmacogenomic strategy for individualizing antidepressant therapy
por: Lin, Keh-Ming, et al.
Publicado: (2008)

Overcoming obstacles to repurposing for neurodegenerative disease
por: Shineman, Diana W, et al.
Publicado: (2014)

Strategies for Treatment of Disease-Associated Dementia Beyond Alzheimer's Disease: An Update
por: Khan, Sabiya Samim, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1gerb1v8fom4nmi9govc6290cr